Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide

Vaccine

Volumn 30, Issue 49, 2012, Pages 7090-7096

  Chang, Janoi ^a   Serrano, Yohanna ^a   Garrido, Raine ^a   Rodríguez, Laura M ^a   Pedroso, Jessy ^a   Cardoso, Felix ^a   Valdés, Yury ^a   García, Dagmar ^a   Fernández Santana, Violeta ^a   Verez Bencomo, Vicente ^a  

^a Center for Biomolecular Chemistry   (Cuba)

Author keywords

Antigenicity; Conjugate vaccine; O acetyl group; Phosphate glycerol; Streptococcus pneumoniae serotype 18C

Indexed keywords

ACETIC ACID DERIVATIVE; BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; GLYCEROPHOSPHOLIPID; PENTASACCHARIDE; PHOSPHATE;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG ANTIGENICITY; DRUG PURIFICATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIGENS, BACTERIAL; HUMANS; PHOSPHOLIPID ETHERS; POLYSACCHARIDES, BACTERIAL; RABBITS; STREPTOCOCCUS PNEUMONIAE;

EID: 84869093567     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.047     Document Type: Article

References (30)

1. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., Lee E., Mulholand K., Levine O., Cherian T., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.
2. American Academy of Pediatrics Committee on Infectious Diseases Policy statement: recommendation for the prevention of pneumococcal infections, including the use of pneumococcal conjugated vaccine (Prevnar), pneumococcal polysaccharide vaccine and antibiotic prophylaxis. Pediatrics 2000, 106:362-366.
3. Rodgersa G.L., Klugman K.P. The future of pneumococcal disease prevention. Vaccine 2011, 29S:C43-C48.
4. Poolman J., Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines 2011, 10:307-322.
5. Berry D.S., Lynn F., Lee C.H., Frasch C.E., Bash M.C. Effect of O-acetylation of Neisseria meningitides serogroup A capsular polysaccharides in sera from vaccines and carriers. Infect Immun 2002, 70:3707-3713.
6. Michon F., Huang C.H., Farley E.K., Hronowski L., Di J., Fusco P.C. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope. Dev Biol (Basel) 2000, 103:151-160.
7. Fernández-Santana V., Cardoso F., Rodriguez A., Carmenate T., Peña L., Valdés Y., Hardy E., Mawas F., Heynngnezz L., Rodríguez M.C., Figueroa I., Chang J., Toledo M.E., Musacchio A., Hernández I., Izquierdo M., Cosme K., Roy R., Verez-Bencomo V. Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b. Infect Immun 2004, 72:7115-7123.
8. Verez-Bencomo V., Fernandez-Santana V., Hardy E., Toledo M.E., Rodriguez A., Baly A., Harrera L., Izquierdo M., Villar A., Valdes Y., Cosme K., Deler M.L., Montane M., Gracia E., Ramos A., Aguilar A., Medina E., Torano G., Sosa I., Hernandez I., Martinez R., Muzachio A., Carmenates A., Costa L., Cardoso F., Campa C., Diaz V., Roy R. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 2004, 305:522-525.
9. Lugowski C., Jennings H.J. Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type 18C (56). Carbohydr Res 1984, 131:119-129.
10. Karmerling J.P., Tomasz A. Pneumococcal Polysaccharide: A Chemical View - Streptococcus pneumoniae - Molecualr Biology and Mechanisms of Disease 2000, Mary Ann Lierbert, Inc., Larchmont, NY, USA, p. 81-114.
11. Richards J.C., Perry M.B. Structure of the specific capsular polysaccharide of Streptococcus pneurnoniae type 23F (American type 23). Biochem Cell Biol 1988, 66:758-771.
12. Bruckner J. Estimation of monosaccharides by the orcinol-sulfuric acid reaction. Biochem J 1995, 60:200-205.
13. Porro M., Vitti S., Antoni G., Neri P. Modifications of Park-Johnson ferricyanide submicromethod for the assay of reducing groups in carbohydrates. Anal Biochem 1981, 118:301-306.
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem 1951, 193:265-275.
15. Che-Jen Lee. Quality control of polyvalent pneumococcal polysaccharide - protein conjugates vaccine by nephelometry. Biologicals 2002, 30:97-103.
16. Romero-Steiner S., Libutti D., Pais L.B., Dykes J., Anderson P., Witin J.C., Keyserling H.L., Carlone G.M. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 Cells. Clin Diagn Lab Immunol 1997, 4:415-422.
17. Jones C. NMR assays for carbohydrate-based vaccines. J Pharm Biomed Anal 2005, 38:840-850.
18. Daum R.S., Hogerman D., Rennels M.B., Bewley K., Malinoski F., Rothstein E., Reisinger K., Block S., Keyserling H., Steinhoff M. Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines. J Infect Dis 1997, 176:445-455.
19. Laferriere C.A., Sood R.K., de Muys J.M., Michon F., Jennings H.J. Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes. Infect Immun 1998, 66:2441-2446.
20. Charlotte C., Yu Ip, Veda Manam, Robert Hepler, John P.Hennessey Carbohydrate composition analysis of bacterial polysaccharides: optimized acid hydrolysis conditions for HPAEC-PAD analysis. Anal Biochem 1992, 201:343-349.
21. Alonso De Velasco E., Verheul A.F.M., van Steijn A.M.P., Dekker H.A.T., Feldman R.G., Fernandez I.M., Kamerling J.P., Vliegenthart J.F.G., Verhoef J., Snippe H. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG. Infect Immun 1994, 62:799-808.
22. Jennings, HJ, Lugowski C. Immunogenic polysaccharide-protein conjugates. Patent 4356170; 1982.
23. Karlsson C., Jansson P., Wildmalm G., Skov Sørensen U.B. Structural elucidation of the capsular polysaccharide from Streptococcus pneumoniae type 18B. Carbohydr Res 1997, 304:165-172.
24. Per-Erik J., Lindberg B., Lindberg J., Henrichsen J. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 18F. Carbohydr Res 1988, 173:217-225.
25. Butler J.C., Breiman R.F., Campbell J.F., Lipman H.B., Broome C.V., Facklam R.R. Pneumococcal polysaccharide vaccine efficacy an evaluation of current recommendations. JAMA 1993, 270:1826-1831.
26. Corné, Stroop J.M., Qiuwei Xu, Retzlaff M., Abeygunawardana Ch., Bush C.A. Structural analysis and chemical depolymerization of the capsular polysaccharide of Streptococcus pneumoniae type 1. Carbohydr Res 2002, 337:335-344.
27. Rajam G., Carlone G.M., Romero-Steiner S. Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C. Clin Vaccine Immunol 2007, 14:1223-1227.
28. Mcneely T.B., Staub J.M., Rusk C.M., Blum M.J., Donnelly J.J. Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques. Infect Immun 1998, 66:3705-3710.
29. Fusco P.C., Farley E.K., Chun-Hsien Huang, Moore S., Michon F. Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation. Clin Vaccine Immunol 2007, 14:577-584.
30. Gudlavalleti S.K., Lee Ch., Norris S.E., Paul-Satyaseela M., Vann W.F., Frasch C.E. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-cetylated and chemically de-O-acetylated polysaccharide. Vaccine 2007, 25:7972-7980.